pentetic acid has been researched along with Tuberous Sclerosis in 4 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.
Excerpt | Relevance | Reference |
---|---|---|
"Findings on cranial magnetic resonance (MR) images were correlated with known histopathologic findings in 42 patients with tuberous sclerosis (TS), 17 of whom received gadopentetate dimeglumine, to extend the range of signs on MR images." | 8.78 | MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. ( Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA, 1992) |
"Findings on cranial magnetic resonance (MR) images were correlated with known histopathologic findings in 42 patients with tuberous sclerosis (TS), 17 of whom received gadopentetate dimeglumine, to extend the range of signs on MR images." | 4.78 | MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. ( Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Muroff, LR | 1 |
Runge, VM | 1 |
Menor, F | 1 |
MartĂ-BonmatĂ, L | 1 |
Mulas, F | 1 |
Poyatos, C | 1 |
Cortina, H | 1 |
Braffman, BH | 1 |
Bilaniuk, LT | 1 |
Naidich, TP | 1 |
Altman, NR | 1 |
Post, MJ | 1 |
Quencer, RM | 1 |
Zimmerman, RA | 1 |
Brody, BA | 1 |
Martin, N | 1 |
Debussche, C | 1 |
De Broucker, T | 1 |
Mompoint, D | 1 |
Marsault, C | 1 |
Nahum, H | 1 |
2 reviews available for pentetic acid and Tuberous Sclerosis
Article | Year |
---|---|
The use of MR contrast in neoplastic disease of the brain.
Topics: Brain; Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Co | 1995 |
MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Topics: Adolescent; Adult; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Dru | 1992 |
2 other studies available for pentetic acid and Tuberous Sclerosis
Article | Year |
---|---|
Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Cerebellar Cortex; Child; Child, Preschool; Contrast Media | 1992 |
Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Calculi; Child; Child, Preschool; Female; Gadoliniu | 1990 |